{
    "organizations": [],
    "uuid": "1117f5cb4af70349701118fc545c5d0c8517bf4f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-suzuken-unit-signs-license-agreeme/brief-suzuken-unit-signs-license-agreement-regarding-sk-1404-for-treatment-of-frequent-urination-at-night-idUSL3N1RB2V2",
    "ord_in_thread": 0,
    "title": "Suzuken unit signs license agreement regarding SK-1404 for treatment of frequent urination at night",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Suzuken Co Ltd\n* Says its unit SANWA KAGAKU KENKYUSHO CO,LTD signs license agreement with KYORIN Pharmaceutical Co Ltd, which is unit of Kyorin Holdings Inc, regarding SK-1404 for treatment of frequent urination at night\nSource text in Japanese: goo.gl/vPFZTf\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-29T14:16:00.000+03:00",
    "crawled": "2018-03-30T13:08:26.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "suzuken",
        "co",
        "ltd",
        "say",
        "unit",
        "sanwa",
        "kagaku",
        "kenkyusho",
        "co",
        "ltd",
        "sign",
        "license",
        "agreement",
        "kyorin",
        "pharmaceutical",
        "co",
        "ltd",
        "unit",
        "kyorin",
        "holding",
        "inc",
        "regarding",
        "treatment",
        "frequent",
        "urination",
        "night",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}